Mohammad Reza Rasouli, MD
Pain Management · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rasouli’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A162868 · Current
Licensed to practise in California · since 2019 · expires 2027-06-30 · Tehran University of Medical Sciences and Health Services.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$87,411
Medicare paid this office $87,411 for 295 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 93 | $18,110 | $115 |
| Long return visit (40+ min) | 42 | $8,542 | $161 |
| New patient visit (45+ min) | 46 | $6,974 | $152 |
| New patient visit (60+ min) | 30 | $5,644 | $188 |
| Short return visit (20+ min) | 30 | $2,726 | $74 |
See all 10 services
| Return visit (30+ min) | 93 | $18,110 | $115 |
| Long return visit (40+ min) | 42 | $8,542 | $161 |
| New patient visit (45+ min) | 46 | $6,974 | $152 |
| New patient visit (60+ min) | 30 | $5,644 | $188 |
| Short return visit (20+ min) | 30 | $2,726 | $74 |
| Injection of trigger points, 3 or more muscles | 19 | $1,982 | $50 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,489 | $41 |
| Insertion of artery tube for blood sampling or infusion through skin | 11 | $411 | $37 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $394 | $10 |
| Injection, ropivacaine hydrochloride, 1 mg | 24 | $94 | None |
Who their Medicare patients are
295 Original Medicare patients in 2024. Average age 72 · Under 65 16% · 85 and older 11% · Women 60% · Also on Medicaid 31% · Health risk score 1.99. Sicker patients than 9 in 10 peers; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 75% · Depression 37% · Chronic kidney disease 34% · Diabetes 33% · Coronary heart disease 29% · Atrial fibrillation 25% · Cancer 24% · Heart failure 22% · COPD 17% · Stroke 12% · Dementia 10%.
The office billed $958,550, Medicare allowed $114,425 and paid $87,411; for 2,808 services of 91 kinds; $1,130 of it was for drugs given in the office and $86,281 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 295 | 2,808 | 72 | 1.99 | $958,550 | $87,411 |
| 2023 | 446 | 1,964 | 71 | 1.83 | $941,295 | $93,467 |
| 2022 | 397 | 991 | 70 | 1.77 | $1,065,291 | $86,840 |
| 2021 | 403 | 673 | 70 | 1.79 | $597,095 | $82,717 |
| 2020 | 138 | 158 | 71 | 1.98 | $260,480 | $33,719 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| New patient visit (45+ min) | 108 | $15,661 | $145 |
| Return visit (30+ min) | 91 | $14,613 | $113 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 133 | $8,858 | $44 |
| Short return visit (20+ min) | 55 | $5,626 | $80 |
| New patient visit (60+ min) | 23 | $4,675 | $203 |
| Long return visit (40+ min) | 23 | $4,347 | $167 |
| Telehealth originating site facility fee | 131 | $4,220 | $22 |
| Daily hospital management of continuous spinal drug administration | 31 | $3,023 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,687 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,281 | $67 |
| Injection of trigger points, 3 or more muscles | 22 | $1,610 | $54 |
| Injection of substance into lower spine canal using imaging guidance | 15 | $1,412 | $88 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 11 | $1,303 | $93 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 48 | $261 | $4 |
2022: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 128 | $13,152 | $64 |
| Return visit (30+ min) | 63 | $12,253 | $116 |
| New patient visit (45+ min) | 63 | $9,091 | $144 |
| Anesthesia for other closed procedure on chest | 14 | $3,599 | $225 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,563 | $122 |
| Daily hospital management of continuous spinal drug administration | 23 | $2,511 | $56 |
| Telehealth originating site facility fee | 70 | $2,368 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,330 | $86 |
| Short return visit (20+ min) | 12 | $1,278 | $85 |
| Injection of trigger points, 3 or more muscles | 13 | $1,129 | $51 |
| Insertion of artery tube for blood sampling or infusion through skin | 14 | $540 | $39 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 31 | $213 | $5 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 28 | $139 | $4 |
2021: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 149 | $17,605 | $66 |
| Anesthesia for extensive surgery on spine | 17 | $8,349 | $491 |
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 35 | $4,492 | $128 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,595 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,235 | $95 |
| Daily hospital management of continuous spinal drug administration | 22 | $2,616 | $57 |
| New patient visit (45+ min) | 15 | $2,352 | $157 |
| Return visit (30+ min) | 17 | $1,699 | $100 |
| Anesthesia for other procedure on large bowel using an endoscope | 12 | $1,621 | $135 |
| Insertion of artery tube for blood sampling or infusion through skin | 24 | $922 | $38 |
| Telehealth originating site facility fee | 13 | $281 | $22 |
2020: 3 services
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 46 | $6,668 | $139 |
| Anesthesia for procedure on gallbladder, pancreas, or liver using an endoscope | 13 | $2,504 | $179 |
| Insertion of artery tube for blood sampling or infusion through skin | 16 | $640 | $40 |
Medicaid work
$337 in 2024
Medicaid paid $337 for 20 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 20 | $337 |
| 2024 | 20 | 1 | 13 | $337 |
| 2023 | 58 | 2 | 14 | $1,053 |
| 2022 | 108 | 1 | 17 | $3,172 |
| 2021 | 116 | 1 | 15 | $3,085 |
| 2020 | 13 | 1 | 12 | $816 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 45 | $920 |
| Telehealth originating site facility fee | 13 | $133 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 108 | $3,172 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 116 | $3,085 |
2020
| Anesthesia for upper gastrointestinal endoscopic procedure proximal to duodenum | 13 | $816 |
Drugs they prescribed that Part D paid
$21,002
Pharmacies billed $21,002 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 28% of their Part D prescriptions (109 of 393) in 2024. At or below the middle of the specialty; the typical pain management clinician is at 44%. Long-acting opioids: 30% of their opioid prescriptions.
371 generic and 22 brand-name prescriptions · $21,002 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 33 | $6,574 | $199 |
| Savella | 13 | $5,987 | $461 |
| Pregabalin | 83 | $1,612 | $19 |
| Hydrocodone-Acetaminophen | 45 | $1,414 | $31 |
| Duloxetine | 62 | $679 | $11 |
See all 10 drugs
| Buprenorphine | 33 | $6,574 | $199 |
| Savella | 13 | $5,987 | $461 |
| Pregabalin | 83 | $1,612 | $19 |
| Hydrocodone-Acetaminophen | 45 | $1,414 | $31 |
| Duloxetine | 62 | $679 | $11 |
| Baclofen | 30 | $377 | $13 |
| Diclofenac | 17 | $336 | $20 |
| Gabapentin | 21 | $303 | $14 |
| Cyclobenzaprine | 11 | $101 | $9 |
| Oxycodone | 11 | $78 | $7 |
Year by year
| 2024 | 393 | 104 | 28% (109) | 6% | $21,002 |
| 2023 | 236 | 85 | 19% (45) | 9% | $16,011 |
| 2022 | 204 | 60 | 25% (50) | 8% | $16,634 |
| 2021 | 31 | 20 | None | None | $3,902 |
| 2020 | 69 | 22 | None | None | $3,779 |
| 2019 | 43 | 20 | None | None | $2,975 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Savella | 16 | $6,584 | $411 |
| Pregabalin | 27 | $2,200 | $81 |
| Lidocaine | 11 | $2,064 | $188 |
| Duloxetine | 52 | $1,182 | $23 |
| Gabapentin | 29 | $549 | $19 |
| Hydrocodone-Acetaminophen | 17 | $247 | $15 |
| Oxycodone-Acetaminophen | 11 | $108 | $10 |
2022: 5 drugs
| Buprenorphine | 15 | $3,860 | $257 |
| Pregabalin | 29 | $1,905 | $66 |
| Duloxetine | 34 | $715 | $21 |
| Gabapentin | 17 | $469 | $28 |
| Hydrocodone-Acetaminophen | 17 | $395 | $23 |
2020: 2 drugs
| Duloxetine | 24 | $514 | $21 |
| Gabapentin | 15 | $399 | $27 |
2019: 1 drug
| Gabapentin | 11 | $362 | $33 |
Money from drug and device companies
$153 in 2025
| 2025 | 1 | 1 | None | $153 |
| 2024 | 1 | 2 | None | $58 |
| 2023 | 5 | 5 | None | $674 |
| 2022 | 3 | 6 | None | $477 |
| 2021 | 1 | 3 | None | $1,275 |
| 2020 | 1 | 1 | None | $64 |
| 2019 | 2 | 3 | None | $285 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bioventus | Stimrouter Implantable Kit | $153 | 1 payment
|
See the published payment
| Bioventus | Meals · 2025-02-13 | Stimrouter Implantable Kit | $153 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $58
| Boston Scientific | Wavewriter Alpha Prime 16 | $58 | 2 payments
|
2023: $674
| Painteq | Painteq | $242 | 1 payment
|
| Nevro | Senza | $136 | 1 payment
|
| Abbott Laboratories | Proclaim | $115 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $103 | 1 payment
|
| Boston Scientific | Spectra Wavewriter | $78 | 1 payment
|
2022: $477
| Relievant Medsystems | Intracept | $422 | 4 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $31 | 1 payment
|
| Nalu Medical | Nalu Neurostimulation System | $24 | 1 payment
|
2021: $1,275
| Nalu Medical | Nalu Neurostimulation System | $1,275 | 3 payments
|
2020: $64
| Boston Scientific | General - Pain Management | $64 | 1 payment
|
2019: $285
| Boston Scientific | General Pain Management | $186 | 2 payments
|
| Avanos Medical | Coolief* Cooled Radiofrequency | $100 | 1 payment
|
Professional record
- NPI
- 1548675259
- Licence
- CA A162868California A162868: Current · expires 2027-06-30
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 207L00000X (207L00000X); Federal specialty code 207LC0200X (207LC0200X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2014-06-23
- NPI last updated
- 2024-04-11
- NPI record certified
- 2024-04-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1500 Lansdowne Ave, Darby, PA, 19023